Black Diamond Therapeutics (BDTX) PT Raised to $44 at JPMorgan, Following Earnings

March 25, 2021 3:00 PM EDT
Get Alerts BDTX Hot Sheet
Price: $25.22 +1.57%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 23 | Down: 22 | New: 25
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

JPMorgan analyst Eric Joseph raised the price target on Black Diamond Therapeutics (NASDAQ: BDTX) to $44.00 (from $43.00) while maintaining a Overweight rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

JPMorgan, Earnings